Navigation Links
Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
Date:5/13/2008

les, which generally carry a lower margin. Two

million dollars of start-up costs associated with the new Monterrey,

Mexico facility and higher fuel and other commodity costs negatively

impacted gross profit and margins.

-- Other operating expenses increased $24.9 million, or 20.4 percent. The

higher expense levels were primarily due to increased spending

previously outlined as part of our strategic plan, including research

and development (up 18.5 percent over the prior year quarter to $14.8

million), higher sales and marketing expenses of 14.8 percent, and

currency impacts. Other unfavorable expense items during the quarter

include non-recurring separation-related charges of $7.3 million, and a

$4.1 million unfavorable swing for self insurance reserves.

Other:

-- Expenses associated with the separation of the health care and funeral

services businesses into independent companies resulted in the

inclusion of the following items in Hill-Rom's income from continuing

operations on a GAAP basis (these items represent pre-tax adjustments

made in determining Hill-Rom's as adjusted fully diluted earnings per

share figure for continuing operations):

-- Stock modification charge of $5.8 million

-- Debt extinguishment costs of $3.2 million

-- Other separation costs of $1.5 million

-- Cash flow from operations, which includes cash flows from the funeral

services business through March 31, 2008, was $84.1 million for the

second quarter, up $49.3 million, or 141.7 percent, from the prior year

comparable period. Substantially all of the increase in cash flow for

the quarter was generated by Hill-Rom.

Please see the attached schedules for additional information, including reconciliations of earnings in accordance with U.S. generally accepted acco
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Hill-Rom to Present at the Citi Healthcare Conference
2. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
4. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
5. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
6. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
7. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
8. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
9. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
10. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
11. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
(Date:7/25/2008)...CHAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Ph...armaceutical company, today announced that it,has ...I antiarrhythmic,indicated for the treatment and p...rillation and hemodynamically unstable ventricular...egular heart beat.,Sagent,s amiodarone HCl injecti...
(Date:7/25/2008)...ARLSBAD, Calif., July 25 /PRNewswire/ -- AutoGenom...stration statement on Form S-1 with the,Securities...initial public,offering of shares of its common st...fered, all of which are expected to be offered by,...fering, have not yet been,determined., J.P. Morga...
(Date:7/25/2008)... New program delivers immediat...ml [24-hour telephone access to language interpre...eking multilingual solutions. , ...-- LLE® http://www.lle-inc.com/index.html [...provider of interpretation, translation, and langu...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
...ptoms of Money sickness syndrome (MSS) due to impr...d by the insurance giant AXA found that Britons ha...ems //due to the feeling that they are not in cont...e Britons have experienced symptoms such as palpit...
...roversy prevails over a case lodged by a wife agai... accused of infecting her with the deadly virus. A.../ status before the marriage. Furthermore, he is s...f HIV infection over a period of 6 months. The wo...
...merican scientist of Indian origin has been declar... a new system which makes use of data for improvin...o is the Senior Director of Engineering Research D...s' Computer-aided Diagnosis and Therapy Group. R...
...has stopped the removing of life support to an 11-...improving after four months in a coma. The coma wa...ved from her stepfather and adoptive mother. The g... months, and her coma was declared irreversible by...
Other Medicine News:
(Date:7/22/2008)...tes Feasibility and Efficacy of Treating Patients ..., SAN FRANCISCO, and YONGIN-SI, South Korea, July... CA and Ottawa, Ontario), and its South,Korean par... findings from,a Phase I clinical trial of its fir...the product was well-tolerated and resulted in cle...
(Date:7/22/2008)...lan Will Stress the Importance to Patients of Pass...l Pathway, RICHMOND, Va., July 22 /PRNewswire-Fir...er of follow-on biologics and biopharmaceuticals, ... Insmed, will present at a,Congressional briefing ...ant need for establishing an approval pathway for ...
(Date:7/22/2008)... Validated by Columbia University Medical Center B...croRNA Technology, The Test Differentiates Squam...(NSCLC), Classifying Squamous-Cell Carcinoma of th...pecificity of 90 Percent,This is the First CLIA Ap... as Biomarkers for Accurate Diagnosis of ...
(Date:7/22/2008)...s an Individual,s Genetic Risk Based on Clinical D... Educational Materials, WALTHAM, Mass., July 22 /.... (Amex: ILI ), today announced the launch of an ...e for the company,s Heart Health Genetic Test.,The...ensona(R) Heart Health,Genetic Test by Quixtar/Amw...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3APC papers in global theme issue on poverty 4283 1Can the Web Transform the U S Healthcare System 3F 4281 1Can the Web Transform the U S Healthcare System 3F 4281 2Can the Web Transform the U S Healthcare System 3F 4281 3DoD and VA to Reduce Healthcare Supply Chain Costs 4279 1DoD and VA to Reduce Healthcare Supply Chain Costs 4279 2DoD and VA to Reduce Healthcare Supply Chain Costs 4279 3DoD and VA to Reduce Healthcare Supply Chain Costs 4279 4New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 1New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 2New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 3New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4277 4
...xas--(BUSINESS WIRE)--Jun 27, 2007 - Opexa,Therape...he,development and commercialization of cell thera...ternational Society for Stem Cell,Research Annual ...rom June 17-20 and at the 13th Annual Meeting of t...T) in Sydney, Australia from June,24-27. The two p...
...SS WIRE)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,G...nd preclinical,data that support the safety, activ...Defibrotide in combination with anticancer,therapy... an update,from the Company,s ongoing Phase I/II c...psed multiple myeloma with Defibrotide in,combinat...
Other Medicine Technology:Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
...leep System is an easy-to-use, workflow-based syst...lts. Inspirex consists of the SleepWorks software...ugged and durable systems can be used for a comple...s - including full EEG recording - and have superi...
...ieval System is made up of three integral componen...ter and the Merci Balloon Guide Catheter. The syst... Once the location of the clot has been identified...er is inserted through a small incision in the fem...
... level of care you can provide to your patients, D...ng innovative products, standardization and reimbu...Davol® pulsed lavage systems deliver the perfo...otic tissue, bacteria, and foreign material. Each ...
The Simpulse Solo Pulsed Lavage System requires minimal set up and has a Wide range of tips available for every orthopaedic procedure. It uses a separate suction lumen to reduce clogging and n ergono
Medicine Products: